Proposal for Parental Guidance and Early Stimulation in Children With Congenital Heart Disease: Randomized Trial
NCT ID: NCT04152330
Last Updated: 2023-06-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
44 participants
INTERVENTIONAL
2019-11-30
2020-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objective: To evaluate the effect of an early stimulation program using parents as vectors of intervention, on the neurodevelopment of children with CHD Methodology: Randomized clinical trial, conducted with 44 dyads of parents-babies with CH considered as medium and high risk for developmental delays according to the guidelines of the American Heart Association (2012). The study will consist of two groups G1 (Intervention) and G2 (controls). G1 parents will receive guidance for 6 weeks of stimulation activities and will be instructed to keep an online execution diary, direct with the researcher through videos, and messages via cell phone. G2 parents will receive the standard guidelines currently used in pediatric cardiology clinics. Children from both groups will be assessed at the beginning and end of the 6 weeks by the Bayley Baby and Toddler Development Scales (3rd Edition). A questionnaire on the applicability of the protocol will be administered to the parents of the intervention group Expected results: Better neuropsychomotor performance in children after applying the early stimulation protocol.
Perspectives: Create a body of information that can serve as a basis for the formulation of policies for intervention and surveillance of the development of this population.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Family Centred Early Intervention of Infants With Congenital Heart Disease
NCT04666857
The Effect of a Nurse-led Continuous Support Program on Neurodevelopment of Preterm Infants
NCT03151122
Motor Development of Children That Have Surgery as Newborns for Complex Congenital Heart Disease
NCT02781545
Creative Music Therapy in Newborns With Congenital Heart Disease
NCT05702203
Support for the Management of Parental Stress in Surgical Resuscitation of Congenital Heart Diseases
NCT06884046
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Comparison between intervention and control group
The subjects will be randomized to two groups, intervention group (IG) and control group (CG). Each day GI Parents-Baby receives guidance for 6 weeks of stimulation activities and will be instructed to keep an online execution diary, directly with the researcher of videos and messages via cell phone. "Parents" is understood as a generalist nomenclature and will be considered a parent, mother or principal.
GC subjects receive standard guidance from the pediatric and pediatric cardiology clinic.
Early stimulation protocol on neuropsychomotor development of children with congenital heart disease
A parenting guidance booklet will be prepared. It will contain a specific program of stimulation activities for each stage of development in simple language and with illustrations. Subdivided into 4 areas: Cognition, Language, Large Motor and Fine Motor. The duration will be 6 weeks. Parents will participate in 1 individual face-to-face meeting, where they will receive information and clarification on the application of the booklet and will have a mobile communication channel to answer questions throughout the process. Parents will be instructed on the capabilities and limitations of their babies according to the child's congenital heart disease, as well as what is expected within the typical development for this age group and the importance of early stimulation activities in each child in 4 areas of development.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Early stimulation protocol on neuropsychomotor development of children with congenital heart disease
A parenting guidance booklet will be prepared. It will contain a specific program of stimulation activities for each stage of development in simple language and with illustrations. Subdivided into 4 areas: Cognition, Language, Large Motor and Fine Motor. The duration will be 6 weeks. Parents will participate in 1 individual face-to-face meeting, where they will receive information and clarification on the application of the booklet and will have a mobile communication channel to answer questions throughout the process. Parents will be instructed on the capabilities and limitations of their babies according to the child's congenital heart disease, as well as what is expected within the typical development for this age group and the importance of early stimulation activities in each child in 4 areas of development.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of congenital heart disease up to 3 months old.
* Stable clinical condition (with medical clearance to receive the intervention), For parents
* Parents are literate
* Acceptance of the Responsible to participate in the research.
* Have a mobile device capable of sending and receiving messages and videos.
Exclusion Criteria
* Suspected or diagnosed genetic syndrome;
* Musculoskeletal or neurological malformation associated
* inability to establish a primary caregiver as in the case of baby under state supervision.
for parents
* Illiteracy
* Presence of deafness, blindness or physical disability, when another family member cannot be responsible for the application of the protocol.
3 Months
9 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Instituto de Cardiologia do Rio Grande do Sul
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fernanda Lucchese, Doutora
Role: PRINCIPAL_INVESTIGATOR
Instituto de cardiologia de porto alegre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Instituto de cardiologia de porto alegre
Porto Alegre, Rio Grande do Sul, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5553/18
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.